Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Engmann

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Reproductive Medicine|July 2, 2015
Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?Alyaa Elassar, John Nulsen, Lawrence Engmann, et al.
Fertility and Sterility|April 26, 2011
Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulationAlyaa Elassar, Lawrence Engmann, John Nulsen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 21, 2006
Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanismLawrence Engmann, Ralf Losel, Martin Wehling, et al.
Fertility and Sterility|October 16, 2004
An unusual anatomic variation of a unicornuate uterus with normal external uterine morphologyLawrence Engmann, David Schmidt, John Nulsen, et al.
Fertility and Sterility|December 23, 2015
Survey assessing obesity policies for assisted reproductive technology in the United StatesLeah Kaye, Carolina Sueldo, Lawrence Engmann, et al.
F&S Reports|September 18, 2023
Macroprolactinemia: a mini-review and update on clinical practiceKatherine Koniares, Claudio Benadiva, Lawrence Engmann, et al.
Fertility and Sterility|May 24, 2011
In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturationLawrence Engmann, Jonathan Romak, John Nulsen, et al.
Fertility and Sterility|March 24, 2010
Endogenous gonadotropin flare following microdose leuprolide (MDL) stimulation protocol does not correlate with in vitro fertilization (IVF) outcomeJessica S Mann, Lawrence Engmann, Claudio A Benadiva, et al.
Fertility and Sterility|August 28, 2010
Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor respondersAlyaa Elassar, Jessica Salas Mann, Lawrence Engmann, et al.
Fertility and Sterility|April 28, 2007
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled studyLawrence Engmann, Andrea DiLuigi, David Schmidt, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Reproductive Medicine|July 2, 2015
Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?Alyaa Elassar, John Nulsen, Lawrence Engmann, et al.
Fertility and Sterility|April 26, 2011
Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulationAlyaa Elassar, Lawrence Engmann, John Nulsen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 21, 2006
Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanismLawrence Engmann, Ralf Losel, Martin Wehling, et al.
Fertility and Sterility|October 16, 2004
An unusual anatomic variation of a unicornuate uterus with normal external uterine morphologyLawrence Engmann, David Schmidt, John Nulsen, et al.
Fertility and Sterility|December 23, 2015
Survey assessing obesity policies for assisted reproductive technology in the United StatesLeah Kaye, Carolina Sueldo, Lawrence Engmann, et al.
F&S Reports|September 18, 2023
Macroprolactinemia: a mini-review and update on clinical practiceKatherine Koniares, Claudio Benadiva, Lawrence Engmann, et al.
Fertility and Sterility|May 24, 2011
In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturationLawrence Engmann, Jonathan Romak, John Nulsen, et al.
Fertility and Sterility|March 24, 2010
Endogenous gonadotropin flare following microdose leuprolide (MDL) stimulation protocol does not correlate with in vitro fertilization (IVF) outcomeJessica S Mann, Lawrence Engmann, Claudio A Benadiva, et al.
Fertility and Sterility|August 28, 2010
Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor respondersAlyaa Elassar, Jessica Salas Mann, Lawrence Engmann, et al.
Fertility and Sterility|April 28, 2007
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled studyLawrence Engmann, Andrea DiLuigi, David Schmidt, et al.
Pageof 6